Zekry HA, Reddy SK
Department of Symptom Control and Palliative Care, University of Texas, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston TX 77030, USA.
Curr Rev Pain. 1999;3(3):237-247. doi: 10.1007/s11916-999-0018-9.
Management of cancer pain has made sidnificant progress in recent years, partly due to the Agency for Health Care Policy and Research (AHCPR) guidelines, but mostly it seems to be due to the death and dying movement in the world. However, cancer pain on occasion poses significant problems and needs accurate diganosis and appropriate intervention. Pharmacotherapy remains the mainstay of treating cancer pain. Most cancer pain syndromes present with moderate to severe pain, associated with several comorbid problems necessitating the multidisciplinary approach to optimally treat it. The psychologic factors associated wth serious illness, terminal prognoses, and dying complicate the scenario even more as compared with that of nonmalignant pain. Although such patients are entitled to more aggressive analgesic therapy, it is unfortunate that this is not achieved in a significant percentage of cases. In this review, we address some of the above issues and attempt to summarize the traditional pharmacologic therapies highlighting their modern modes of implementation in cancer pain management. Special emphasis on the state-of-the art innovations in this field wil be noted.
近年来,癌症疼痛的管理取得了显著进展,部分原因是医疗保健政策与研究机构(AHCPR)的指南,但主要似乎是由于全球的死亡与临终关怀运动。然而,癌症疼痛有时会带来重大问题,需要准确诊断和适当干预。药物治疗仍然是治疗癌症疼痛的主要手段。大多数癌症疼痛综合征表现为中度至重度疼痛,伴有多种合并症,需要采用多学科方法进行最佳治疗。与非恶性疼痛相比,与重病、晚期预后和临终相关的心理因素使情况更加复杂。尽管这类患者有权接受更积极的镇痛治疗,但遗憾的是,在很大比例的病例中并未实现这一点。在本综述中,我们讨论上述一些问题,并试图总结传统药物治疗方法,突出其在癌症疼痛管理中的现代应用方式。将特别强调该领域的最新创新。